Why Expertise Matters in Target Expression and Assay Development for Cancer Clinical Trials
Make better clinical trial decisions by working with a biomarker expert to adopt clinical trial ready IHC assays early in the drug development process
September 26, 2022
Read More
Advancing Cell Therapy Success in Solid Tumors
CAR-T cell therapy has proven highly successful in treating hematological cancers and the race is on to extend cellular therapies to a wider range of cancers.
August 10, 2022
Read More
SpecimenSeq Cancer Tissue Samples with Known Mutations
Thousands of tissue samples with full genotyping data make cohort selection a breeze. SpecimenSeq: Saving time, reducing cost, and accelerating research
July 6, 2022
Read More
Visualizing Patterns and Trends Across Cancer Types Using DTCs
Analyzing thousands of cancer tissue samples in the form of DTCs provides insights into the nature of different cancer indications
June 28, 2022
Read More
Getting The Most from Dissociated Tissue & Tumor Cells
Best practices in the processing and analysis of dissociated tissue cell samples deliver insights into disease and reveal new therapeutic targets
June 21, 2022
Read More
Dissociated Tumor Cells: The Key to Next-Generation Therapy
Dissociated tissue cell (DTC) samples maximize value and usability of fresh tissues to rapidly advance oncology research at any scale
June 15, 2022
Read More
5 Questions to Ask Your FFPE Provider (and What Their Answers Should Be)
FFPE tissue samples are critical for research, but are you getting what you think? A few simple questions can help validate your supplier and give confidence in your samples.
May 26, 2022
Read More
Optimizing Viability for Cryopreserved Leukopaks
May 5, 2022
Setting up for success: How proper handling and processing pre-freeze can ensure the maximum levels of cell viability after cryopreservation.
Read More
Cryopreserved Leukopaks: Addressing the Viability Myth
April 28, 2022
Recent publications, including a landmark paper from Novartis¹, demonstrate the viability and utility of cryopreserved leukopaks, dispelling the viability myth.
Read More
Addressing the Achilles Heel of T-Cell Therapy
April 18, 2022
Cryopreserved leukopaks eliminate the constraints imposed by a reliance on fresh human cells for T-cell therapies. Has the tide turned in favor of frozen cells?
Read More
To propel your projects with The Power of Discovery.™
Contact Us Today
Let us know about your project!
